RRM2B is frequently amplified across multiple tumor types: non-oncogenic addiction and therapeutic opportunities
Iqbal, W.; Demidova, E.; Serrao, S.; ValizadehAslani, T.; Rosen, G.; arora, s.
Show abstract
RRM2B plays a crucial role in DNA replication, repair and oxidative stress. While germline RRM2B mutations have been implicated in mitochondrial disorders, its relevance to cancer has not been established. Here, using TCGA data, we investigated RRM2B alterations in cancer. We found that RRM2B is highly amplified in multiple tumor types, particularly in MYC-amplified tumors, and is associated with increased RRM2B mRNA expression. We also observed that the chromosomal region 8q22.3-8q24, is amplified in multiple tumors, and includes RRM2B, MYC along with several other cancer-associated genes. An analysis of genes within this 8q-amplicon showed that cases that have both RRM2B-amplified along with MYC have a distinct pattern of amplification compared to unaltered cases or cases that have amplifications in RRM2B or MYC only. These other 8q-proteins were shown to interact functionally within the RRM2B network of DNA repair, hypoxia and apoptosis regulating proteins. Notably, RRM2B-amplified tumors are characterized by mutation signatures of defective DNA repair and oxidative stress, and in some cancers also associated with poor clinical outcome. These findings suggest that some cancers may require RRM2B for cellular survival, providing novel therapeutic opportunities in these cancers.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- The role of KPNA2 mutations in breast cancer prognosis: A survey of publicly available databases 95%
- An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types 94%
- NSMCE2, a Novel Super-Enhancer Regulated Gene, is Linked to Poor Prognosis and Therapy Resistance in Breast Cancer 94%
Similar papers in this journal
- Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers 96%
- Metastasis is altered through multiple processes regulated by the E2F1 transcription factor 96%
- Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases 95%
Similar papers in this journal
- Molecular diagnosis and prognosis of cancers of unknown-primary (CUPs): progress from a microRNA-based droplet digital PCR assay 95%
- Expression and DNA methylation of 20S proteasome subunits as prognostic and resistance markers in cancer 95%
- TPX2 expression promotes sensitivity to dasatinib in breast cancer by activating the YAP transcriptional signaling. 94%
Similar papers in this journal
- A meta-analysis of clinical cases of reversion mutations in BRCA genes identifies signatures of DNA end-joining repair mechanisms driving therapy resistance 93%
- Prevalence and mutational determinants of high tumor mutation burden in breast cancer 92%
- Frequency of mutations in 21 hereditary breast and ovarian cancer susceptibility genes among high-risk Chinese individuals 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.